
What We’re Reading: Oklahoma Supreme Court Opioid Ruling; Psilocybin as Depression Treatment; Bedtime and Heart Disease Risk
The Supreme Court of Oklahoma ruled that Johnson & Johnson cannot be held liable for the state’s opioid crisis; a trial found the psychedelic drug psilocybin may be a highly efficacious therapy for treatment-resistant depression; people who went to bed at midnight or later had a 25% greater risk of cardiovascular disease.
Johnson & Johnson Found Not Liable for Oklahoma Opioid Crisis
In a 5-to-1 decision, the Supreme Court of Oklahoma found Johnson & Johnson cannot be held liable for the state’s opioid crisis,
Study Finds Psilocybin Highly Efficacious as Depression Therapy
The psychedelic drug psilocybin was found to be highly efficacious as a therapy for treatment-resistant depression,
Falling Asleep Between 10 and 11 PM Linked with Lower Cardiovascular Risk, Study Shows
A report published in European Heart Journal Digital Health found that cardiovascular events incidents were lowest in people who fell asleep between 10 and 11 PM,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.